Comparison
Aars1 Related Leukoencephalopathy Cn379160 vs 17p11 2 Microduplication Syndrome C2931246
Clinical comparison between Aars1 Related Leukoencephalopathy CN379160 and 17p11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
Aars1 Related Leukoencephalopathy Cn379160
A rare genetic condition affecting the brain's white matter, caused by mutations in the AARS1 gene. It can cause movement problems, developmental delays, and other neurological symptoms.
17p11 2 Microduplication Syndrome C2931246
A chromosomal condition involving duplication on chromosome 17, related to Potocki-Lupski syndrome. Features often include developmental delays, learning challenges, and distinctive facial features.
6 comparison axes
Onset
Aars1 Related Leukoencephalopathy Cn379160
0-60
17p11 2 Microduplication Syndrome C2931246
0-null
Onset patterns differ
Severity
Aars1 Related Leukoencephalopathy Cn379160
severe
17p11 2 Microduplication Syndrome C2931246
moderate
Different severity levels
Chronic
Aars1 Related Leukoencephalopathy Cn379160
Chronic
17p11 2 Microduplication Syndrome C2931246
Chronic
Differing course
Communicable
Aars1 Related Leukoencephalopathy Cn379160
No
17p11 2 Microduplication Syndrome C2931246
No
Different transmission
Body System
Aars1 Related Leukoencephalopathy Cn379160
neurologic
17p11 2 Microduplication Syndrome C2931246
congenital
Same/different system
Category
Aars1 Related Leukoencephalopathy Cn379160
neurologic
17p11 2 Microduplication Syndrome C2931246
genetic
Different category
Bottom line
aars1-related-leukoencephalopathy-CN379160 and 17p11-2-microduplication-syndrome-C2931246 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Aars1 Related Leukoencephalopathy Cn379160 | 17p11 2 Microduplication Syndrome C2931246 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described with neurologic and movement problems | Often accompanied by learning challenges | Low |
| White-matter involvement | Suggested by the leukoencephalopathy designation | Not established as a defining feature | High |
| Facial appearance | Distinctive facial features are not established | Distinctive facial features are often described | Moderate |
When to favor each condition
Choose Aars1 Related Leukoencephalopathy Cn379160 when
Neurologic signs suggest white-matter disease
The source links AARS1 variants to leukoencephalopathy
Moderate
Movement problems occur with developmental delay
These neurologic features are described for the left condition
Low
An AARS1 variant has been reported
Gene findings need phenotype correlation and specialist review
Moderate
Choose 17p11 2 Microduplication Syndrome C2931246 when
Congenital delay includes learning difficulties
This pattern fits the described chromosomal syndrome
Moderate
Facial features accompany developmental concerns
Facial findings are suggestive but not diagnostic alone
Low
Testing shows a 17p11.2 duplication
The result supports the diagnosis after clinical correlation
High
How key tests differ
| Test | Aars1 Related Leukoencephalopathy Cn379160 | 17p11 2 Microduplication Syndrome C2931246 | Interpretation |
|---|---|---|---|
| Brain MRI | White-matter abnormality may be present; pattern unspecified | No specific MRI finding is established here | An MRI abnormality is a finding, not a diagnosis |
| Genetic testing | AARS1 sequencing or a gene panel may be considered | Chromosomal microarray can detect 17p11.2 duplication | Laboratory results require clinician interpretation |
| Developmental assessment | May document neurologic and motor delay | May document learning and developmental challenges | Overlap is expected and does not replace genetic diagnosis |
Prognosis comparison
Aars1 Related Leukoencephalopathy Cn379160
- Outcome
- Described as severe and chronic, but individual outcome is not established
- Factors
- Neurologic burden, movement problems, and developmental delay
17p11 2 Microduplication Syndrome C2931246
- Outcome
- Described as moderate and chronic, with variable learning needs
- Factors
- Developmental profile, learning challenges, and congenital features
Time frame: Lifelong; supplied onset information is limited and differs
Etiology, severity, and supportive care; prognosis must be individualized
Complications comparison
| Complication | Presentation |
|---|---|
| Motor impairment | Movement problems are described Not specifically established by the source Course and severity vary; progression should not be assumed |
| Learning difficulty | Developmental delay may affect learning Learning challenges are often described Educational support should be individualized |
| Overall medical burden | Source severity is severe Source severity is moderate Specific complications and mortality are not established |
Patient education highlights
- HighGenetic cause
Neither condition is communicable. Genetics counseling may help families understand inheritance and testing.
- HighDiagnostic limits
An abnormal scan or laboratory result is not itself a diagnosis and needs appropriate confirmation.
- MediumSupportive care
Therapy and schooling depend on individual needs. No treatment dose is established here.